comprehensive -WSS

comprehensive

author：comprehensive 2025-10-02 01:04:48 - browse：92

a person uses a smart phone with both fingers in the dark – first opinion coverage from STAT — Adobe

In May, a National Public Radio story asked, “Can a chatbot help people with eating disorders as well as another human?”

It focused on a chatbot that we developed to prevent eating disorders and help people with body image concerns and who are otherwise not likely to have access to other resources. We’ve committed our careers to increasing detection of eating disorders and access to care, and we received research funding from the National Eating Disorders Association (NEDA) to create and evaluate a chatbot called Tessa in hopes of preventing eating disorders and helping to address the problem that once individuals develop eating disorders, less than 20% ever receive any care.

The NPR story and coverage that followed led to a tremendous backlash for a couple of reasons. Some of those reasons are fair and are related to a technical problem — more on that in a minute.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The high cost of giving birth even with insurance
Next article： STAT Summit: Ending the crisis of Black deaths in the U.S.

WSS

Smaller biotechs seek to piggyback on weight loss drug boom

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

STAT Readout Newsletter: Biotech news today

Merck, Daiichi strike cancer drug pact worth up to $22 billion

Why a market frenzy over new weight loss drugs defies logic

Scientists boost immune system in aging mice by making it youthful

entertainment

comprehensive

Wikipedia

In Memoriam: Notable people who died in 2023

Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

Walensky prepares to leave CDC — and Congress — behind

The Readout: Lenmeldy, GLP

Hepatitis C has a cure — but many Americans still lack access to it

The Readout: Lenmeldy, GLP

Guidelines to prevent youth baseball injuries need more muscle

UnitedHealth, Optum discontinue NaviHealth name

FDA approval of Sarepta Duchenne genetic therapy gives me hope

FDA clears Verve to begin U.S. study of gene

hotspot

Readout Newsletter: Merck, Vertex, and Viking updates

Covid vaccine financial winners and losers, from Pfizer to Novavax

Vertex Pharmaceuticals may move headquarters in Boston

Donor acceptance rates hint at racial, gender bias in heart transplants: study

Health tech investors get more selective as pandemic boom fades

FDA's naming rule on biosimilars has undermined competition

leisure time

leisure time

knowledge

hotspot